documents: FDA-1996-D-0048-0005
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1996-D-0048-0005 | FDA | FDA-1996-D-0048 | Q3B(R) Impurities in New Drug Products (Revision 2) | Other | Guidance | 2006-08-04T04:00:00Z | 2006 | 8 | 2020-06-02T04:00:00Z | 2024-11-15T02:00:46Z | 1 | 0 | 09000064846c4e6f |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref